Revvity (RVTY) EPS (Diluted) Growth (3y) (2012 - 2026)
Revvity (RVTY) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.52% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -6.10% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 16.91% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 5.61% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -2.93% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 42.83% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 6.03% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 10.87% |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn | -26.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -26.00% |
| Dec 28, 2025 | -54.66% |
| Sep 28, 2025 | -26.81% |
| Jun 29, 2025 | -27.61% |
| Mar 30, 2025 | 27.74% |
| Dec 29, 2024 | -0.81% |
| Sep 29, 2024 | -64.27% |
| Jun 30, 2024 | -42.09% |
| Mar 31, 2024 | -31.20% |
| Oct 1, 2023 | -724.91% |
| Apr 2, 2023 | 2,026.63% |
| Jan 1, 2023 | 722.38% |
| Oct 2, 2022 | 546.76% |
| Jul 3, 2022 | 561.54% |
| Apr 3, 2022 | -434.10% |
| Jan 2, 2022 | 481.09% |
| Oct 3, 2021 | 160.66% |
| Jul 4, 2021 | 215.39% |
| Apr 4, 2021 | 847.95% |
| Jan 3, 2021 | 70.00% |